Intellia Therapeutics - investor relations

Skip to main navigation

Contact
Info
CRISPR/Cas9
Programs
Investors & Media
Careers

stock information

Copyright West LLC. Minimum 15 minutes delayed.

press releases

–

Feb 27, 2020

Summary Toggle Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results

events and presentation

There are currently no events to display.

corporate governance

corporate governance

financial information

financial information

stock<br />
information

stock
information

investor<br />
FAQs

investor
FAQs

information<br />
request

information
request

IR<br />
contacts

IR & Media
contacts

analyst coverage

Info

Overview
Leadership
Partners

Careers

Our DNA
Why We’re Here
Job Openings
Benefits

CRISPR/Cas9

What’s CRISPR/Cas9?
How CRISPR/Cas9 Works
Types of Edits

Programs

Our Full-Spectrum Approach
Pipeline
In Vivo Therapies
Ex Vivo Therapies

Investors & Media

Press Releases
Scientific Publications and Presentations
Corporate Deck
Events & Presentations
Press Kit

© Intellia Therapeutics 2020

terms of use
privacy policy

Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.